17-18173861-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016239.4(MYO15A):​c.10431T>C​(p.Tyr3477Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.745 in 1,613,820 control chromosomes in the GnomAD database, including 450,805 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.78 ( 46714 hom., cov: 34)
Exomes 𝑓: 0.74 ( 404091 hom. )

Consequence

MYO15A
NM_016239.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.791

Publications

26 publications found
Variant links:
Genes affected
MYO15A (HGNC:7594): (myosin XVA) This gene encodes an unconventional myosin. This protein differs from other myosins in that it has a long N-terminal extension preceding the conserved motor domain. Studies in mice suggest that this protein is necessary for actin organization in the hair cells of the cochlea. Mutations in this gene have been associated with profound, congenital, neurosensory, nonsyndromal deafness. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Read-through transcripts containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternatively spliced transcript variants have been described, but their full length sequences have not been determined. [provided by RefSeq, Jul 2008]
MYO15A Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 17-18173861-T-C is Benign according to our data. Variant chr17-18173861-T-C is described in ClinVar as Benign. ClinVar VariationId is 45744.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.867 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO15ANM_016239.4 linkc.10431T>C p.Tyr3477Tyr synonymous_variant Exon 65 of 66 ENST00000647165.2 NP_057323.3 Q9UKN7-1
MYO15AXM_017024715.3 linkc.10434T>C p.Tyr3478Tyr synonymous_variant Exon 63 of 64 XP_016880204.1
MYO15AXM_017024714.3 linkc.10371T>C p.Tyr3457Tyr synonymous_variant Exon 62 of 63 XP_016880203.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO15AENST00000647165.2 linkc.10431T>C p.Tyr3477Tyr synonymous_variant Exon 65 of 66 NM_016239.4 ENSP00000495481.1 Q9UKN7-1

Frequencies

GnomAD3 genomes
AF:
0.779
AC:
118554
AN:
152146
Hom.:
46649
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.874
Gnomad AMI
AF:
0.657
Gnomad AMR
AF:
0.775
Gnomad ASJ
AF:
0.802
Gnomad EAS
AF:
0.641
Gnomad SAS
AF:
0.586
Gnomad FIN
AF:
0.747
Gnomad MID
AF:
0.775
Gnomad NFE
AF:
0.753
Gnomad OTH
AF:
0.773
GnomAD2 exomes
AF:
0.734
AC:
181585
AN:
247468
AF XY:
0.724
show subpopulations
Gnomad AFR exome
AF:
0.871
Gnomad AMR exome
AF:
0.784
Gnomad ASJ exome
AF:
0.809
Gnomad EAS exome
AF:
0.639
Gnomad FIN exome
AF:
0.749
Gnomad NFE exome
AF:
0.746
Gnomad OTH exome
AF:
0.753
GnomAD4 exome
AF:
0.742
AC:
1083874
AN:
1461556
Hom.:
404091
Cov.:
71
AF XY:
0.736
AC XY:
535235
AN XY:
727092
show subpopulations
African (AFR)
AF:
0.878
AC:
29405
AN:
33480
American (AMR)
AF:
0.783
AC:
34994
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.808
AC:
21124
AN:
26136
East Asian (EAS)
AF:
0.643
AC:
25523
AN:
39700
South Asian (SAS)
AF:
0.589
AC:
50800
AN:
86258
European-Finnish (FIN)
AF:
0.752
AC:
39954
AN:
53110
Middle Eastern (MID)
AF:
0.766
AC:
4416
AN:
5768
European-Non Finnish (NFE)
AF:
0.748
AC:
832325
AN:
1111994
Other (OTH)
AF:
0.751
AC:
45333
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
18388
36776
55164
73552
91940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20292
40584
60876
81168
101460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.779
AC:
118680
AN:
152264
Hom.:
46714
Cov.:
34
AF XY:
0.775
AC XY:
57671
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.874
AC:
36333
AN:
41568
American (AMR)
AF:
0.775
AC:
11860
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.802
AC:
2784
AN:
3470
East Asian (EAS)
AF:
0.641
AC:
3316
AN:
5172
South Asian (SAS)
AF:
0.586
AC:
2831
AN:
4834
European-Finnish (FIN)
AF:
0.747
AC:
7909
AN:
10592
Middle Eastern (MID)
AF:
0.772
AC:
227
AN:
294
European-Non Finnish (NFE)
AF:
0.753
AC:
51192
AN:
68016
Other (OTH)
AF:
0.772
AC:
1631
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1350
2700
4050
5400
6750
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
862
1724
2586
3448
4310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.761
Hom.:
119180
Bravo
AF:
0.787
Asia WGS
AF:
0.607
AC:
2113
AN:
3478
EpiCase
AF:
0.733
EpiControl
AF:
0.734

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Tyr3477Tyr in Exon 65 of MYO15A: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 24.0% (1601/6668) of European American chromosomes from a broad population by the NHLBI Exome Sequ encing Project (http://evs.gs.washington.edu/EVS; dbSNP rs854800). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 3 Benign:3
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
0.10
DANN
Benign
0.52
PhyloP100
-0.79
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs854800; hg19: chr17-18077175; COSMIC: COSV52753907; COSMIC: COSV52753907; API